CTLA4 and cancer: Analysis of the IRS within the tumor showed that the immune-high subtype was characterized by significantly higher levels of CTLA-4 expression in cancer cells compared to the immune-low subtype (Mann–Whitney test p < 0.0001; Figure S7A,B).